Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026)
Cartesian Therapeutics' EBITDA came in at -$28.13 million for Q2 2026, compared with -$21.04 million a year earlier.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBITDA (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cartesian Therapeutics reported EBITDA of -$151.87 million; for FY2025, it came in at -$139.67 million.
- Going back by year, EBITDA was -$40.31 million in FY2024, -$83.82 million in FY2023, $17.16 million in FY2022 and -$2.23 million in FY2021.
- The five-year range for quarterly EBITDA is -$77.82 million (Q4 2025) to $14.55 million (Q2 2024).
- Business Quant data shows RNAC's EBITDA at -$25.65 million (Q1 2026), -$77.82 million (Q4 2025) and -$20.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Cartesian Therapeutics | 210.06 Mn | -304.30 Mn | - | -23.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -23.97 Mn |
| Jun 30, 2026 | -28.13 Mn |
| Mar 31, 2026 | -25.65 Mn |
| Sep 30, 2025 | -20.47 Mn |
| Jun 30, 2025 | -21.21 Mn |
| Mar 31, 2025 | -20.55 Mn |
| Dec 31, 2024 | -25.57 Mn |
| Sep 30, 2024 | -16.64 Mn |
| Jun 30, 2024 | 14.55 Mn |
| Mar 31, 2024 | -12.65 Mn |
| Dec 31, 2023 | -35.58 Mn |
| Sep 30, 2023 | -12.44 Mn |
| Jun 30, 2023 | -18.04 Mn |
| Mar 31, 2023 | -17.76 Mn |
| Dec 31, 2022 | -7.85 Mn |
| Sep 30, 2022 | -910,000.00 |
| Jun 30, 2022 | 14.50 Mn |
| Mar 31, 2022 | 11.42 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | -1.35 Mn |
API Access
Cartesian Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();